<DOC>
	<DOCNO>NCT01338077</DOCNO>
	<brief_summary>About 60 % patient typical gastroesophageal reflux symptom heartburn regurgitation consider non-erosive reflux disease ( NERD ) . Patients NERD show overall poor response PPI treatment patient erosive reflux disease . Sodium alginate oral suspension medication indicate relief gastroesophageal reflux symptom . This multi-center , double blind , randomize trial aim compare efficacy safety profile sodium alginate oral suspension ( 50 mg/ml ) 20 ml three time daily omeprazole ( 20 mg/capsule ) 1 capsule daily treatment NERD patient Taiwan . Efficacy assessment include percentage patient achieve adequate relief heartburn regurgitation 4 week treatment , improvement reflux symptom assess reflux disease questionnaire treatment , patient overall satisfaction end study . Safety assessment include incidence adverse event change laboratory test result . The study hypothesis treatment sodium alginate non-inferior omeprazole relieve heartburn regurgitation symptom NERD patient .</brief_summary>
	<brief_title>Efficacy Safety Sodium Alginate Oral Suspension Treat Non-erosive Gastro-esophageal Reflux Disease</brief_title>
	<detailed_description>This multi-center , double blind , randomize trial aim compare efficacy safety profile sodium alginate oral suspension ( 50 mg/ml ) 20 ml three time daily omeprazole ( 20 mg/capsule ) 1 capsule daily treatment non-erosive reflux disease ( NERD ) patient Taiwan . Patients include study diagnose NERD ; heartburn regurgitation ( either one ) main symptom least 2 day week present ≧1 month screening ; heartburn regurgitation ( either one ) 7 day screen period , either frequency ≧4 day mild symptom , ≧ 2 day moderate severe symptom ; sign informed consent . Patients exclude diagnosed erosive gastroesophageal reflux disease ( GERD ) , Barrett 's esophagus esophageal stricture ; active heal gastroduodenal ulcer ( except scar ) ; history gastric , duodenal esophageal surgery ; intrahepatic stone , gallstone , gallbladder sludge , hepatic pancreatic carcinoma evidence abdominal ultrasonography , ischemic heart disease evidence electrocardiogram ; take proton pump inhibitor ( PPI ) within 14 day screen , H2-blocker , prokinetic agent antacid within 7 day screen ; clinically significant liver kidney disease . The primary efficacy endpoint percentage patient achieve adequate heartburn ( define burn feeling pain behind breast bone ) regurgitation ( defined acid taste mouth unpleasant movement material upwards stomach ) relief day 28 assess patient diary . The secondary efficacy endpoint percentage patient achieve adequate heartburn regurgitation relief day 14 ; change baseline reflux disease questionnaire total score day 14 &amp; 28 ; patient ' overall satisfaction end study ; number antacid use 4-week treatment period . The safety endpoint incidence adverse event , change laboratory test result ( hematology , biochemistry , urinalysis ) . The study hypothesis treatment sodium alginate non-inferior omeprazole relieve heartburn regurgitation symptom NERD patient .</detailed_description>
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Heartburn</mesh_term>
	<mesh_term>Omeprazole</mesh_term>
	<mesh_term>Alginic acid</mesh_term>
	<criteria>Patients age 2075 year old ( inclusive ) Taiwan gender Outpatients diagnose nonerosive gastroesophageal reflux disease ( NERD ) Patients heartburn regurgitation ( either one ) main symptom least 2 day week present &gt; = 1 month screen Patients heartburn regurgitation ( either one ) 7 day screen period , either frequency &gt; = 4 day mild symptom , &gt; = 2 day moderate severe symptom Patients sign informed consent form Patients erosive gastroesophageal reflux disease ( GERD ) , Barrett 's esophagus esophageal stricture Patients active heal gastroduodenal ulcer ( except scar ) Patients history gastric , duodenal esophageal surgery Patients malignant disease kind Patients intrahepatic stone , gallstone , gallbladder sludge , hepatic pancreatic carcinoma evidence abdominal ultrasonography Patients ischemic heart disease evidence electrocardiogram Female patient pregnant nursing mother Patients history allergy study drug related compound Patients history alcohol drug abuse Patients clinically significant liver disease ( aspartate aminotransferase ( AST ) , alanine aminotransferase ( ALT ) &gt; 2 upper limit normal ) Patients clinically significant renal disease ( serum creatinine &gt; 1.5 mg/dl ) Patients take proton pump inhibitor ( PPI ) within 14 day screen , H2blocker , prokinetic agent antacid within 7 day screen Patients participate investigational drug trial within 4 week screen Patients condition disease investigator considers appropriate enter study</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Alginate</keyword>
	<keyword>Gastroesophageal reflux disease</keyword>
</DOC>